These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1010 related articles for article (PubMed ID: 11280761)

  • 21. Identification of signal-induced IkappaB-alpha kinases in human endothelial cells.
    Bennett BL; Lacson RG; Chen CC; Cruz R; Wheeler JS; Kletzien RF; Tomasselli AG; Heinrikson RL; Manning AM
    J Biol Chem; 1996 Aug; 271(33):19680-8. PubMed ID: 8702671
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Statins prevent NF-kappaB transactivation independently of the IKK-pathway in human endothelial cells.
    Hölschermann H; Schuster D; Parviz B; Haberbosch W; Tillmanns H; Muth H
    Atherosclerosis; 2006 Apr; 185(2):240-5. PubMed ID: 16051251
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fisetin, an inhibitor of cyclin-dependent kinase 6, down-regulates nuclear factor-kappaB-regulated cell proliferation, antiapoptotic and metastatic gene products through the suppression of TAK-1 and receptor-interacting protein-regulated IkappaBalpha kinase activation.
    Sung B; Pandey MK; Aggarwal BB
    Mol Pharmacol; 2007 Jun; 71(6):1703-14. PubMed ID: 17387141
    [TBL] [Abstract][Full Text] [Related]  

  • 24. VEGF expression in human macrophages is NF-kappaB-dependent: studies using adenoviruses expressing the endogenous NF-kappaB inhibitor IkappaBalpha and a kinase-defective form of the IkappaB kinase 2.
    Kiriakidis S; Andreakos E; Monaco C; Foxwell B; Feldmann M; Paleolog E
    J Cell Sci; 2003 Feb; 116(Pt 4):665-74. PubMed ID: 12538767
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hepatocyte growth factor suppresses vascular endothelial growth factor-induced expression of endothelial ICAM-1 and VCAM-1 by inhibiting the nuclear factor-kappaB pathway.
    Min JK; Lee YM; Kim JH; Kim YM; Kim SW; Lee SY; Gho YS; Oh GT; Kwon YG
    Circ Res; 2005 Feb; 96(3):300-7. PubMed ID: 15637298
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Protein kinase CK2 promotes aberrant activation of nuclear factor-kappaB, transformed phenotype, and survival of breast cancer cells.
    Romieu-Mourez R; Landesman-Bollag E; Seldin DC; Sonenshein GE
    Cancer Res; 2002 Nov; 62(22):6770-8. PubMed ID: 12438279
    [TBL] [Abstract][Full Text] [Related]  

  • 27. PTK787/ZK 222584, a novel and potent inhibitor of vascular endothelial growth factor receptor tyrosine kinases, impairs vascular endothelial growth factor-induced responses and tumor growth after oral administration.
    Wood JM; Bold G; Buchdunger E; Cozens R; Ferrari S; Frei J; Hofmann F; Mestan J; Mett H; O'Reilly T; Persohn E; Rösel J; Schnell C; Stover D; Theuer A; Towbin H; Wenger F; Woods-Cook K; Menrad A; Siemeister G; Schirner M; Thierauch KH; Schneider MR; Drevs J; Martiny-Baron G; Totzke F
    Cancer Res; 2000 Apr; 60(8):2178-89. PubMed ID: 10786682
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Complete inhibition of vascular endothelial growth factor (VEGF) activities with a bifunctional diabody directed against both VEGF kinase receptors, fms-like tyrosine kinase receptor and kinase insert domain-containing receptor.
    Lu D; Jimenez X; Zhang H; Wu Y; Bohlen P; Witte L; Zhu Z
    Cancer Res; 2001 Oct; 61(19):7002-8. PubMed ID: 11585724
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Acute alcohol inhibits the induction of nuclear regulatory factor kappa B activation through CD14/toll-like receptor 4, interleukin-1, and tumor necrosis factor receptors: a common mechanism independent of inhibitory kappa B alpha degradation?
    Mandrekar P; Dolganiuc A; Bellerose G; Kodys K; Romics L; Nizamani R; Szabo G
    Alcohol Clin Exp Res; 2002 Nov; 26(11):1609-14. PubMed ID: 12436048
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Vascular endothelial growth factor KDR receptor signaling potentiates tumor necrosis factor-induced tissue factor expression in endothelial cells.
    Shen BQ; Lee DY; Cortopassi KM; Damico LA; Zioncheck TF
    J Biol Chem; 2001 Feb; 276(7):5281-6. PubMed ID: 11058594
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Suppression of RelA/p65 nuclear translocation independent of IkappaB-alpha degradation by cyclooxygenase-2 inhibitor in gastric cancer.
    Wong BC; Jiang Xh; Fan XM; Lin MC; Jiang SH; Lam SK; Kung HF
    Oncogene; 2003 Feb; 22(8):1189-97. PubMed ID: 12606945
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of NF-kappaB signaling in hepatocyte growth factor/scatter factor-mediated cell protection.
    Fan S; Gao M; Meng Q; Laterra JJ; Symons MH; Coniglio S; Pestell RG; Goldberg ID; Rosen EM
    Oncogene; 2005 Mar; 24(10):1749-66. PubMed ID: 15688034
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vascular endothelial growth factor (VEGF)-driven actin-based motility is mediated by VEGFR2 and requires concerted activation of stress-activated protein kinase 2 (SAPK2/p38) and geldanamycin-sensitive phosphorylation of focal adhesion kinase.
    Rousseau S; Houle F; Kotanides H; Witte L; Waltenberger J; Landry J; Huot J
    J Biol Chem; 2000 Apr; 275(14):10661-72. PubMed ID: 10744763
    [TBL] [Abstract][Full Text] [Related]  

  • 34. N-Acetyl-L-cysteine and pyrrolidine dithiocarbamate inhibited nuclear factor-kappaB activation in alveolar macrophages by different mechanisms.
    Li YQ; Zhang ZX; Xu YJ; Ni W; Chen SX; Yang Z; Ma D
    Acta Pharmacol Sin; 2006 Mar; 27(3):339-46. PubMed ID: 16490171
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The protein tyrosine kinase inhibitor SU5614 inhibits VEGF-induced endothelial cell sprouting and induces growth arrest and apoptosis by inhibition of c-kit in AML cells.
    Spiekermann K; Faber F; Voswinckel R; Hiddemann W
    Exp Hematol; 2002 Jul; 30(7):767-73. PubMed ID: 12135675
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Persistent activation of nuclear factor-kappaB in cultured rat hepatic stellate cells involves the induction of potentially novel Rel-like factors and prolonged changes in the expression of IkappaB family proteins.
    Elsharkawy AM; Wright MC; Hay RT; Arthur MJ; Hughes T; Bahr MJ; Degitz K; Mann DA
    Hepatology; 1999 Sep; 30(3):761-9. PubMed ID: 10462383
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of pharmacologic antagonists of epidermal growth factor receptor, PI3K and MEK signal kinases on NF-kappaB and AP-1 activation and IL-8 and VEGF expression in human head and neck squamous cell carcinoma lines.
    Bancroft CC; Chen Z; Yeh J; Sunwoo JB; Yeh NT; Jackson S; Jackson C; Van Waes C
    Int J Cancer; 2002 Jun; 99(4):538-48. PubMed ID: 11992543
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ursolic acid inhibits nuclear factor-kappaB activation induced by carcinogenic agents through suppression of IkappaBalpha kinase and p65 phosphorylation: correlation with down-regulation of cyclooxygenase 2, matrix metalloproteinase 9, and cyclin D1.
    Shishodia S; Majumdar S; Banerjee S; Aggarwal BB
    Cancer Res; 2003 Aug; 63(15):4375-83. PubMed ID: 12907607
    [TBL] [Abstract][Full Text] [Related]  

  • 39. NF-kappaB p105 is a target of IkappaB kinases and controls signal induction of Bcl-3-p50 complexes.
    Heissmeyer V; Krappmann D; Wulczyn FG; Scheidereit C
    EMBO J; 1999 Sep; 18(17):4766-78. PubMed ID: 10469655
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Heterogeneous requirement of IkappaB kinase 2 for inflammatory cytokine and matrix metalloproteinase production in rheumatoid arthritis: implications for therapy.
    Andreakos E; Smith C; Kiriakidis S; Monaco C; de Martin R; Brennan FM; Paleolog E; Feldmann M; Foxwell BM
    Arthritis Rheum; 2003 Jul; 48(7):1901-12. PubMed ID: 12847684
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 51.